CLSA Slashes Bud APAC Target Price by 29.9% to HK$6.1, Keeps Outperform Rating

Deep News10-31

CLSA has released a research report stating that demand in the Chinese and South Korean beer markets remains weak, with low visibility for a recovery, and rising aluminum prices adding cost pressure. As a result, the brokerage has grown more cautious on Bud APAC's (01876) revenue and margin outlook for 2027. CLSA maintains its Outperform rating but has cut its target price by 29.9% from HK$8.7 to HK$6.1.

The brokerage forecasts that Bud APAC (01876) will see continued volume declines in its West region during the fourth quarter of this year and through 2027, partially offset by strong growth in India. Total revenue is expected to fall 6.9% year-on-year in the fourth quarter of this year and decline 1.3% year-on-year in 2027.

Citing weakening operating leverage along with rising aluminum costs and transportation expenses, CLSA has lowered its margin forecasts. Normalized EBITDA is projected to drop 16% year-on-year in the fourth quarter of this year and fall 5% year-on-year in 2027. The brokerage has also revised down its forecasts for 2026 to 2028, cutting revenue estimates by 3% to 7%, reducing non-GAAP normalized EBITDA forecasts by 10% to 17%, and lowering net profit projections by 19.2%, 30%, and 29.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment